SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,964 | +2.3% | 1,555,514 | +16.0% | 0.01% | 0.0% |
Q2 2023 | $35,152 | +399.4% | 1,340,630 | +390.3% | 0.01% | +400.0% |
Q1 2023 | $7,039 | +13.4% | 273,427 | +14.6% | 0.00% | 0.0% |
Q4 2022 | $6,207 | -99.9% | 238,653 | -4.1% | 0.00% | 0.0% |
Q3 2022 | $7,101,000 | +19.5% | 248,855 | +3.1% | 0.00% | 0.0% |
Q2 2022 | $5,944,000 | -66.6% | 241,443 | -23.5% | 0.00% | -50.0% |
Q1 2022 | $17,804,000 | -7.9% | 315,442 | +1.1% | 0.00% | 0.0% |
Q4 2021 | $19,340,000 | -0.8% | 312,041 | +1.5% | 0.00% | 0.0% |
Q3 2021 | $19,502,000 | -23.4% | 307,407 | -0.5% | 0.00% | 0.0% |
Q2 2021 | $25,459,000 | +5.6% | 308,937 | -5.7% | 0.00% | 0.0% |
Q1 2021 | $24,107,000 | +1.9% | 327,679 | +0.5% | 0.00% | 0.0% |
Q4 2020 | $23,655,000 | – | 326,180 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |